Targeting Checkpoint Kinase 1 in Cancer Therapeutics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting Checkpoint Kinase 1 in Cancer Therapeutics

Published:2007-04-01 Issue:7 Volume:13 Page:1955-1960
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Tse Archie N.,Carvajal Richard,Schwartz Gary K.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule agents for triple negative breast cancer: Current status and future prospects;Translational Oncology;2024-03

2. IN SILICO MOLECULAR SCREENING AND DOCKING APPROACHES ON ANTINEOPLASTIC AGENT-IRINOTECAN TOWARDS THE MARKER PROTEINS OF COLON CANCER;International Journal of Applied Pharmaceutics;2023-09-07

3. Radiation-induced bystander effect and its clinical implications;Frontiers in Oncology;2023-04-05

4. TPP1 Inhibits DNA Damage Response and Chemosensitivity in Esophageal Cancer;Critical Reviews in Eukaryotic Gene Expression;2023

5. Elucidating the structure and cytochrome P450-mediated mechanism for novel metabolites of GDC-0575 in rats;Xenobiotica;2022-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP